Latest / The Full Ratchet (TFR): Venture Capital and Startup Investing Demystified

403. Can BioTech Extend Life to 150 Years? Gene Editing, and Investing in the Future of Life Sciences (Risa Stack)
Risa Stack of The Production Board joins Nate to discuss Can BioTech Extend Life to 150 Years? Gene Editing, and Investing in the Future of Life Sciences. In this episode we cover:
Entrepreneurship, Venture Capital, and Starting Companies
Venture Studio Model, Technical Risk, and Investing in Businesses
Challenges in Therapeutic Development and Commercialization
Prioritizing People Over Products, and Assessing the Funding Environment for Critical Industries
Biotech, Life Extension, and Investment Strategies
Gene Editing and Cell Therapy Technologies
Personalized Medicine
Guest Links:
LinkedIn…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.